Kursprognose für Teva Pharmaceutical Industries Limited.. (TEVA)TEVATeva Pharmaceutical Industries Limited..

Alphio's TEVA stock price prediction model matches the current Teva Pharmaceutical Industries Limited.. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.20 (-0.72%). The 1-week path is $42.51 (+2.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Teva Pharmaceutical is a good buy right now due to its recent FDA approval of Weltruza, which has the potential to significantly increase market share in the mental health sector. The current price is $41.50, and analysts have set a price target range between $50 and $55, indicating a potential upside of 20% to 32%. Additionally, the stock has shown strong momentum with a 1-year change of +113.70% and a 20-day change of +6.46%. However, the main risk is the recent insider selling, which has increased by 764.83%, suggesting potential concerns among insiders about the company's future performance.

Teva Pharmaceutical Industries Limited.. (TEVA) last closed at $41.5, gaining +0.95%. These facts feed the 1-day and 1-week TEVA price prediction above.